|
SocialPicks Sentiment:
N/A
** not enough data to be rated
|
This Quarter's Sentiment:
|
|
|
SocialPicks Community
FDA Calendar Updates: AZN, BMY, OSUR, CPD, INSM, H. Lundbeck
CPD
|
|
|
<> Below is a summary of updates to the <font> BioMedReports.com FDA Calendar </font> , which includes a database of over 200 entries. The calendar was originally created by Mike Havrilla to track companies with pending new drug, biological agent, or medical device new product decisions at the FDA. With the launch of <font> BioMedReports.com </font> , the FDA Calendar has expanded to include the following categories: pending new submissions to the FDA (e.g. NDA, BLA, 510k, PMA, sNDA, sBLA filings), pending complete response letter (CRL) re-submissions to the FDA, and pending late-st>...
|
Caraco Pharma (AMEX:CPD): Poised for a Turnaround
CPD
|
|
|
On 5/28/09, Caraco Pharma (AMEX:CPD) reported its fiscal year 2009 (FY09) results and provided an update on the status of a recently completed FDA inspection of the Company's manufacturing facilities in Detroit, MI. Net sales for CPD declined by 4% for FY09 to a level of $337.2M (versus $350.4M for FY08). The Company cited lower sales of its manufactured products, price erosion for both manufactured + distributed generic drugs, and a voluntary product recall (of heart drug digoxin) during late FY09 for the revenue shortfall. <> Net income decreased to $20.5M during FY09 compa>...
|
BioMedReports.com Most Popular Links
CPD
Bullish on CPD ...
CPD
|
|
|
Caraco Pharmaceutical Laboratories, Ltd. engages in the development, manufacture, and marketing of generic, prescription, and over-the-counter pharmaceuticals. The company offers Allopurinol, an anti-gout; Amifostine for injection used as oncology adjunct; Amlodipine Besylate tablets, Atenolol, Carvedilol, and Metoprolol Tartrate, which are antihypertensive drug/beta blockers; Baclofen and Tizanidine, which are skeletal muscle relaxants; Carbamazepine, Gabapentin, Phenytoin Sodium extended release capsules, Zonisamide, and Oxcarbazepine, which are anticonvulsants; Carbidopa and Levodopa ER ...
|
Three Oversold Healthcare Catalyst Stocks
CPD
|
|
|
Three Oversold Healthcare Catalyst Stocks With the S&P 500 SPDR ETF (SPY) trading about 8% below its 50-day moving average (DMA), I went in search of oversold healthcare stocks trading at least 16% below their 50 DMA which have potential catalysts within the next six months that may provide some very nice returns. <> The Healthcare Sector SPDR (XLV) is trading about 12% below its 50 DMA amidst concerns of sweeping healthcare reform that would threaten the profits of health insurers, managed care companies, big pharma, and biotechs – although such concerns may be ove><>><>><>><>><>><>><>><><><>>><>>><>><>><>><>><>><>><><><>>><>>><>><><><>>><>>><>><>><>><>><>><>><>><><><>>><>>>...
|
|
ROCK-STAR INVESTORS
|
|
POPULAR STOCKS
|
|
TODAY'S HEADLINES
|
|
TODAY'S TOP PICKS
|
|
|
Visit streetinsider.com
Be the first to start a discussion and earn 2 points.
More Resources
|